These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 16604240)

  • 1. Salmonella-based plague vaccines for bioterrorism.
    Calhoun LN; Kwon YM
    J Microbiol Immunol Infect; 2006 Apr; 39(2):92-7. PubMed ID: 16604240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague.
    Leary SE; Griffin KF; Garmory HS; Williamson ED; Titball RW
    Microb Pathog; 1997 Sep; 23(3):167-79. PubMed ID: 9281474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects for new plague vaccines.
    Feodorova VA; Corbel MJ
    Expert Rev Vaccines; 2009 Dec; 8(12):1721-38. PubMed ID: 19943765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Yersinia pestis V antigen in attenuated salmonella typhimurium: development of a novel vaccine for plague.
    Leary SE; Eley SM; Williamson ED; Titball RW
    Contrib Microbiol Immunol; 1995; 13():216-7. PubMed ID: 8833838
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple antigens of Yersinia pestis delivered by live recombinant attenuated Salmonella vaccine strains elicit protective immunity against plague.
    Sanapala S; Rahav H; Patel H; Sun W; Curtiss R
    Vaccine; 2016 May; 34(21):2410-2416. PubMed ID: 27060051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy of a recombinant plague vaccine when co-administered with another sub-unit or live attenuated vaccine.
    Griffin K; Bedford R; Townson K; Phillpotts R; Funnell S; Morton M; Williamson D; Titball R
    FEMS Immunol Med Microbiol; 2005 Mar; 43(3):425-30. PubMed ID: 15708318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral vaccination against plague using Yersinia pseudotuberculosis.
    Demeure CE; Derbise A; Carniel E
    Chem Biol Interact; 2017 Apr; 267():89-95. PubMed ID: 27046452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single component two-valent LcrV-F1 vaccine protects non-human primates against pneumonic plague.
    Chichester JA; Musiychuk K; Farrance CE; Mett V; Lyons J; Mett V; Yusibov V
    Vaccine; 2009 May; 27(25-26):3471-4. PubMed ID: 19200825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Protective activity of the recombinant strain Salmonella minnesota R595/GSA, synthesizing the plague capsule antigen in experimental plague in mice].
    Gremiakova TA; Stepanshina VN; Korobova OV; Anisimov GA
    Mol Gen Mikrobiol Virusol; 1994; (1):23-6. PubMed ID: 8133846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Yersinia pestis guaBA mutant is attenuated in virulence and provides protection against plague in a mouse model of infection.
    Oyston PC; Mellado-Sanchez G; Pasetti MF; Nataro JP; Titball RW; Atkins HS
    Microb Pathog; 2010 May; 48(5):191-5. PubMed ID: 20096773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Salmonella enterica serovar Typhi vaccine expressing Yersinia pestis F1 antigen on its surface provides protection against plague in mice.
    Morton M; Garmory HS; Perkins SD; O'Dowd AM; Griffin KF; Turner AK; Bennett AM; Titball RW
    Vaccine; 2004 Jun; 22(20):2524-32. PubMed ID: 15193377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague.
    Branger CG; Fetherston JD; Perry RD; Curtiss R
    Adv Exp Med Biol; 2007; 603():387-99. PubMed ID: 17966435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live-attenuated Yersinia pestis vaccines.
    Wang X; Zhang X; Zhou D; Yang R
    Expert Rev Vaccines; 2013 Jun; 12(6):677-86. PubMed ID: 23750796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plague.
    Williamson ED
    Vaccine; 2009 Nov; 27 Suppl 4():D56-60. PubMed ID: 19837288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Yersinia pestis YscN ATPase mutant functions as a live attenuated vaccine against bubonic plague in mice.
    Bozue J; Cote CK; Webster W; Bassett A; Tobery S; Little S; Swietnicki W
    FEMS Microbiol Lett; 2012 Jul; 332(2):113-21. PubMed ID: 22537022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs.
    Feodorova VA; Pan'kina LN; Savostina EP; Sayapina LV; Motin VL; Dentovskaya SV; Shaikhutdinova RZ; Ivanov SA; Lindner B; Kondakova AN; Bystrova OV; Kocharova NA; Senchenkova SN; Holst O; Pier GB; Knirel YA; Anisimov AP
    Vaccine; 2007 Nov; 25(44):7620-8. PubMed ID: 17913308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE; Butcher WA; Titball RW; Hill J
    Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of YadC protein delivered by live attenuated Salmonella as a vaccine against plague.
    Sun W; Olinzock J; Wang S; Sanapala S; Curtiss R
    Pathog Dis; 2014 Mar; 70(2):119-31. PubMed ID: 23913628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A live attenuated strain of Yersinia pestis KIM as a vaccine against plague.
    Sun W; Six D; Kuang X; Roland KL; Raetz CR; Curtiss R
    Vaccine; 2011 Apr; 29(16):2986-98. PubMed ID: 21320544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and screening of attenuated ΔphoP/Q Salmonella typhimurium vectored plague vaccine candidates.
    Sizemore DR; Warner EA; Lawrence JA; Thomas LJ; Roland KL; Killeen KP
    Hum Vaccin Immunother; 2012 Mar; 8(3):371-83. PubMed ID: 22327496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.